Directors

 

Brett Hickey
Founder & President
Sergio Fernandez De Cordova
Director
Dr. Safi Bahcall
Director
Katherine Kennedy
Director
Max Lugavere
Creative Director
Gary Finiguerra
Legal Advisor
Dr. Brian Kantor
Director
Caitlin Paulsson
Executive Director
 
Dr. Safi Bahcall
Director

Dr. Bahcall co-founded Synta Pharmaceuticals, which discovers and develops novel drugs for cancer and inflammatory diseases, in July 2001, and has been Chief Executive Officer and a member of the board of directors since then.  He has led Synta through multiple acquisitions, financings, an initial public offering, and the establishment of integrated, multi-product drug discovery and development organization. Prior to founding Synta, Dr. Bahcall was a consultant at McKinsey & Company advising investment banks and pharmaceutical companies on strategy, technology, and operations. Dr. Bahcall also co-founded a drug discovery company focused on novel ion channel research, now part of Synta.

Dr. Bahcall received his B.A. summa cum laude from Harvard University, was awarded his Ph.D. from Stanford University in theoretical physics, and was a Miller postdoctoral fellow at U.C. Berkeley.  In 2008, Dr. Bahcall was named Ernst & Young New England Biotechnology/Pharmaceutical Entrepreneur of the Year.